Extended access to the National Diabetes Services Scheme (NDSS)

More than half of Australia’s Type 1 Diabetes sufferers did not have access to essential subsidies under the National Diabetes Services Scheme - placing a potentially life-saving medical device out of their financial reach.

The National Diabetes Services Scheme established in 1987 and administered by Diabetes Australia aims to enhance the capacity of people with diabetes to understand and self-manage their condition - including timely, reliable and affordable access to the NDSS support services and products.

Under the scheme, around 59,000 Australians were subsidised to use a Continuous Glucose Monitoring (CGM) device to monitor glucose levels around the clock. But, a further 71,000 Australians have not been eligible for financial assistance, taking the price of the device for them from $32.50 per month to a prohibitive $5,000 per year.

H/Advisors APA’s client Ypsomed Australia is a leading developer and manufacturer of medical devices including insulin pumps and is committed to facilitating more accessible solutions to one of Australia’s fastest growing chronic conditions.

H/Advisors APA worked with Ypsomed in the leadup to the 2022 Federal election – securing a commitment by both the Coalition and ALP to opening access to financial support to all Australians with diabetes.

Click here for media coverage on the announcement.